Innoviva, Inc. (INVA) vs Rapport Therapeutics, Inc. Common Stock (RAPP)

A side-by-side comparison of Innoviva, Inc. and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Innoviva, Inc. logo
INVA
Innoviva, Inc.
$1.54B
$20.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Rapport Therapeutics, Inc. Common Stock logo
RAPP
Rapport Therapeutics, Inc. Common Stock
$1.49B
$31.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — INVA vs RAPP

growth of $100 · dividends reinvested · last 2y
INVA +28.7% (+13.4%/yr)RAPP +54.8% (+24.4%/yr)RAPP compounded faster over this window
50100150200250Start $10020252026$129$155
INVA RAPP

INVA vs RAPP: by the numbers

  • •INVA is the larger company ($1.54B vs $1.49B market cap).
  • •INVA is profitable (80.56% net margin) while RAPP runs a net loss (-685.80%).

Metrics side by side

Valuation

MetricINVARAPP
P/E ratio5.08N/A
Forward P/E8.61N/A
PEG ratio0.49N/A
P/S ratio3.4774.49
P/B ratio1.253.52
EV / EBITDA4.90N/A
FCF yield12.25%N/A

Profitability

MetricINVARAPP
Gross margin73.09%0.00%
Operating margin36.66%0.00%
Net margin80.56%-685.80%
ROE28.97%-32.43%
ROIC8.36%-35.66%

Growth (annualized)

MetricINVARAPP
Revenue CAGR (5Y)3.94%N/A
EPS CAGR (5Y)12.71%N/A
FCF CAGR (5Y)-10.54%N/A
Total return CAGR (5Y)4.52%N/A

Frequently asked

Is INVA or RAPP more profitable?
INVA runs the higher net margin — INVA at 80.56% versus RAPP at -685.80%.

Go deeper

Full INVA analysisFull RAPP analysisInteractive comparison tool

Dig into the metrics

Innoviva P/E ratioInnoviva ROERapport Therapeutics, Inc. Common Stock ROEInnoviva operating marginRapport Therapeutics, Inc. Common Stock operating marginInnoviva revenue growthRapport Therapeutics, Inc. Common Stock revenue growthInnoviva free cash flowRapport Therapeutics, Inc. Common Stock free cash flow

Innoviva & Rapport Therapeutics, Inc. Common Stock appear in these rankings

Highest ROE StocksHighest Operating Margin StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.